Cellectar Biosciences, Inc. Restricted Cash and Cash Equivalents
Cellectar Biosciences, Inc. (CLRB) had Restricted Cash and Cash Equivalents of $0 as of 2019-12-31, per its 10-K filed 2020-03-09.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-03-09
- 2019-12-31: Restricted Cash and Cash Equivalents $0.00.
- 2019-09-30: Restricted Cash and Cash Equivalents $0.00.
- 2019-06-30: Restricted Cash and Cash Equivalents $0.00.
- 2019-03-31: Restricted Cash and Cash Equivalents $0.00.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-09 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-12 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-06 |
| 2018-12-31 | $55.00K 10-K · filed 2020-03-09 |
| 2018-09-30 | $55.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $55.00K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $55.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $55.00K 10-K · filed 2019-02-26 |
| 2017-09-30 | $55.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $55.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $55.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $55.00K 10-K · filed 2018-03-21 |
| 2016-09-30 | $55.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $55.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $55.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $55.00K 10-K · filed 2017-03-15 |
| 2015-09-30 | $55.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $55.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $55.00K 10-Q · filed 2015-05-20 |
| 2014-12-31 | $55.00K 10-K/A · filed 2016-10-20 |
| 2013-12-31 | $2.00M 10-K · filed 2014-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |